Skip to main content
Top
Published in: Journal of General Internal Medicine 10/2017

01-10-2017 | Letter to the Editor

Who Gets Testosterone?

Author: Jeffrey L. Jackson, MD MPH

Published in: Journal of General Internal Medicine | Issue 10/2017

Login to get access

Excerpt

Hypogonadism in males is common, with a prevalence of symptomatic androgen deficiency of 5–12% in males between 40 and 70 years of age.1, 2 Jasuja and colleagues explored the pattern of testosterone prescribing using VA administrative data, linking prescription fills to ICD-9 codes 1. In previous work, this group demonstrated that 16% of VA veterans are prescribed testosterone without undergoing the recommended workup 2. In this study, they found that only 6% of men had a diagnosis that would justify receiving testosterone treatment. They conclude that 94% of testosterone receipts in the VA are off-label purposes 3. If this were true, it would be disturbing . It would also fly in the face of most measures demonstrating that the VA matches or exceeds care quality indicators compared to non-VA settings and would contradict the groups own previous work, in which 84% of veterans given testosterone had an appropriate workup prior to testosterone initiation 4. …
Literature
1.
go back to reference Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86(2):724–31.CrossRefPubMed Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86(2):724–31.CrossRefPubMed
2.
go back to reference Travison TG, Araujo AB, O’Donnell AB, Kupelian V, McKinlay JB. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab. 2007;92(1):196–202CrossRefPubMed Travison TG, Araujo AB, O’Donnell AB, Kupelian V, McKinlay JB. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab. 2007;92(1):196–202CrossRefPubMed
3.
go back to reference Jasuja GK, Bhasin S, Reisman JI, Hanlon JT, Miller DR, Morreale AP, Pogach LM, Cunningham FE, Park A, Berlowitz DR, Rose AJ. Who gets testosterone? Patient characteristics associated with testosterone prescribing in the veteran affairs system: a cross-sectional study. J Gen Intern Med. doi: 10.1007/s11606-016-3940-7 Jasuja GK, Bhasin S, Reisman JI, Hanlon JT, Miller DR, Morreale AP, Pogach LM, Cunningham FE, Park A, Berlowitz DR, Rose AJ. Who gets testosterone? Patient characteristics associated with testosterone prescribing in the veteran affairs system: a cross-sectional study. J Gen Intern Med. doi: 10.​1007/​s11606-016-3940-7
4.
go back to reference Jasuja GK, Bhasin S, Reisman JI, Berlowitz DR, Rose AJ. Ascertainment of testosterone prescribing practices in the VA. Med Care. 2015;53(9):746–52.CrossRefPubMed Jasuja GK, Bhasin S, Reisman JI, Berlowitz DR, Rose AJ. Ascertainment of testosterone prescribing practices in the VA. Med Care. 2015;53(9):746–52.CrossRefPubMed
Metadata
Title
Who Gets Testosterone?
Author
Jeffrey L. Jackson, MD MPH
Publication date
01-10-2017
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 10/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4112-0

Other articles of this Issue 10/2017

Journal of General Internal Medicine 10/2017 Go to the issue

Clinical Practice: Clinical Images

Nutritional Deficiency and Acquired Ichthyosis

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.